Learning to recognize the signs and symptoms of stress

Learning to recognize the signs and symptoms of stress

I used to think stress always looked like a dramatic meltdown. You know, ugly crying, yelling into a pillow, eating a bag of cheese curls while binge-watching trashy TV. (Been there, no regrets.) But stress is sneakier than that. She doesn’t always knock loudly. Sometimes she’ll tiptoe in wearing…

Can artificial intelligence improve chronic disease management?

There’s been much excitement lately around artificial intelligence (AI) — especially since generative AI became widely accessible. What used to be a complex, almost unreachable tool is now part of daily conversations, transforming the way we work, learn, and live. It brings a mix of emotions: optimism that it could…

Generalized MG severity tied to misdiagnosis, certain symptoms

People with generalized myasthenia gravis (gMG) who were misdiagnosed at least once and who have certain disease symptoms are more likely to see an increase in disease severity, according to a recent study. Ocular symptoms and/or muscle aches after physical activity were significantly associated with a higher risk of…

Rituximab treatment effective for 4-year-old’s MuSK-MG: Report

Rituximab may be safe and effective in treating young children with myasthenia gravis (MG) driven by antibodies that target muscle-specific tyrosine kinase (MuSK), according to a report detailing the case of a 4-year-old girl. The girl was one of the youngest MG patients to have received rituximab, according…

Diverse mechanisms found for myasthenia gravis’ AChR antibodies

Disease-causing antibodies from different myasthenia gravis (MG) patients bind to and affect the function of acetylcholine receptors (AChRs) in different ways, a study finds. While the mechanism varied, all the antibodies ultimately interfered with the usual activation of AChRs, which are the proteins important for normal muscle contractions commonly…

How I manage my image to live with myasthenia gravis

I recently made peace with the fact that we almost always judge the book by its cover. It’s just what humans do. We believe what we see. And having a disease that’s not always visible has been the biggest challenge of my life. I often look just tired enough to…

Symptoms of gMG controlled with long-term nipocalimab treatment

Long-term treatment with nipocalimab led to sustained reductions in symptom severity among antibody-positive patients with generalized myasthenia gravis (gMG) in a Phase 3 clinical trial. That’s according to new data presented by its developer, Johnson & Johnson, at the American Academy of Neurology (AAN) Annual Meeting this…